Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05447130
Other study ID # PEX2019
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2019
Est. completion date December 31, 2020

Study information

Verified date September 2022
Source Minia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To study corneal endothelial cells changes after phacoemulsification in patients with senile cataract and pseudoexfoliation syndrome (PEX) compared with control patients with senile cataract using specular microscope.


Description:

In a prospective interventional case-control study, 20 eyes with cataract and PEX and 20 control eyes with cataract without PXE were subjected to phacoemulsification and posterior chamber foldable intraocular lens implantation in Minia University Hospital and Genaidy Eye Center between March 2019 and December 2020. Specular microscopy was done preoperatively, 3 and 6 months postoperatively. Endothelium cell density (ECD), coefficient variation (CV), hexagonality, pleomorphism and corneal thickness were evaluated and compares between PXE and control eyes.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 31, 2020
Est. primary completion date December 20, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - senile cataract age more than 55 years Exclusion Criteria: - PEX with glaucoma, eyes with cornea guttata or any corneal dystrophy, zonular dehiscence, very dense nuclear cataract (cataracta nigra) history of previous ocular surgery.

Study Design


Intervention

Procedure:
phacoemulsification
phacoemulsification with corneal endothelial evaluation by specular microscopy

Locations

Country Name City State
Egypt Minia University Hospital Minya Minia

Sponsors (1)

Lead Sponsor Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary corneal endothelial cell loss corneal endothelial cell loss 6 months
See also
  Status Clinical Trial Phase
Completed NCT00121147 - Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan N/A
Recruiting NCT06053554 - Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome N/A
Enrolling by invitation NCT04590651 - Cataract Surgery in Patients With Pseudoexfoliation and Pseudoexfoliation Glaucoma N/A
Not yet recruiting NCT04274634 - The Oscillation of Crystalline and Intraocular Lenses
Not yet recruiting NCT03265457 - The Endothelial Count in Pxf
Completed NCT02137161 - Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery Phase 4
Completed NCT06121154 - Pseudoexfoliation Syndrome, Sarcopenia and Chronic Pain
Terminated NCT00690222 - Intracameral Mydriasis Versus Topical Mydriasis in Cataract Surgery N/A
Completed NCT00327613 - Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma N/A
Recruiting NCT05156138 - The Possible Association Between Pseudoexfoliation Syndrome And Corneal Endothelial Cell Changes
Completed NCT01298895 - Optical Low Coherence Reflectometry Enables Preoperative Detection of Zonular Weakness in Pseudoexfoliation Syndrome N/A
Recruiting NCT01515735 - LOXL1 Polymorphism in Pseudoexfoliation Syndrome N/A
Terminated NCT00546013 - Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome N/A
Completed NCT05113121 - Correlation Between Pupil Size and Ocular Signs of Pseudoexfoliation Syndrome
Completed NCT01767012 - Aqueous Flare of a Hydrophobic Acrylic Single-piece Open-loop IOL With Modified Material Surface Properties Phase 4
Completed NCT03453827 - Long-term Intraocular Lens (IOL) Decentration and Tilt in Eyes With Pseudoexfoliation Syndrome (PES) Following Cataract Surgery N/A